By Mike Barrett
Following the results of 2 clinical trials, the Food and Drug Administration has issued warnings for diabetes medications containing saxagliptin and alogliptin. These medications have been shown to increase the risk of heart failure, especially for those who already suffer from heart or kidney disease.
An FDA statement notes:
“Healthcare professionals should consider discontinuing medications containing saxagliptin and alogliptin in patients who develop heart failure and monitor their diabetes control. If a patient’s blood sugar level is not well-controlled with their current treatment, other diabetes medicines may be required.”
- The trial focusing on saxagliptin found that 3.5% of patients receiving the drug …read more
Read more here: naturalsociety.com
- Rating:
- Views:632 views
- Categories: Health
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr